切换至 "中华医学电子期刊资源库"

中华胃肠内镜电子杂志 ›› 2022, Vol. 09 ›› Issue (03) : 152 -155. doi: 10.3877/cma.j.issn.2095-7157.2022.03.008

综述

长链非编码RNA在胃肠道间质瘤中的研究进展
高福来1, 赵东强1,()   
  1. 1. 050000 石家庄,河北医科大学第二医院消化内科
  • 收稿日期:2021-11-28 出版日期:2022-08-15
  • 通信作者: 赵东强
  • 基金资助:
    河北省重点研发计划国际科技合作专项项目(18397738D)

Research progress of long noncoding RNA in gastrointestinal stromal tumor

Fulai Gao1, Dongqiang Zhao1,()   

  1. 1. Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang 050000, China
  • Received:2021-11-28 Published:2022-08-15
  • Corresponding author: Dongqiang Zhao
引用本文:

高福来, 赵东强. 长链非编码RNA在胃肠道间质瘤中的研究进展[J]. 中华胃肠内镜电子杂志, 2022, 09(03): 152-155.

Fulai Gao, Dongqiang Zhao. Research progress of long noncoding RNA in gastrointestinal stromal tumor[J]. Chinese Journal of Gastrointestinal Endoscopy(Electronic Edition), 2022, 09(03): 152-155.

长链非编码RNA(lncRNA)是一类长度超过200个核苷酸的非蛋白质编码转录本,具有调控基因表达但不表现任何蛋白质编码功能的非编码RNA(ncRNA),目前已成为继microRNA之后又一研究的新热。lncRNA利用修饰、指引和支架三种主要作用模式通过表观遗传学调控、转录调控、转录后调控等机制参与调控消化系统肿瘤的进展。胃肠道间质瘤(GIST)是消化道最常见的间叶源性肿瘤,其发生主要源自于KIT基因或血小板源性生长因子受体α(PDGFRA)基因的突变所致。本文就lncRNA在GIST发病中的作用作一综述。

Long noncoding RNA (lncRNA), a class of transcripts with a length of more than 200 nucleotides, noncoding RNAs (ncRNA) that regulate gene expression but do not exhibit any protein coding function, has become a new hot topic following the microRNA study. lncRNA uses three main modes of action: modification, guidance, and scaffolding to participate in the regulation of digestive system tumor progression through epigenetic regulation, transcriptional regulation, post-transcriptional regulation and other mechanisms. Gastrointestinal Stromal Tumor(GIST)are the most common mesenchymal-derived tumors of the digestive tract, mainly due to mutations in the kit gene or the Platelet-Derived Growth Factor Receptor alpha (PDGFRα) gene. This article reviews the role of lncRNA in the pathogenesis of gastrointestinal stromal tumor.

[1]
Mazur MT, Clark HB.Gastric stromal tumors. Reappraisal of histogenesis[J].Am J Surg Pathol19837(6):507-519.
[2]
Mavroeidis L, Metaxa-Mariatou V, Papoudou-Bai A,et al.Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT/PDGFRA genes and novel genomic alterations:results from a 20-year cohort of patients with GIST from north-western Greece[J].ESMO Open20183(3):e000335.
[3]
Mi R, Ding J, Dong Q,et al.Research progress of genes associated with gastrointestinal stromal tumors[J].Chin J Gen Surg201827(10):1341-1347.
[4]
Chen LP, Yu ZJ, Chen HX.Value of endoscopic ultrasonography combined with Ki-67 and DOG1 expression in the diagnosis of gastrointestinal stromal tumor and evaluation of its risk classifications[J].Hunan Normal Univ(Med Sci), 2021, 18(6): 232-236.
[5]
Yin XN, Yin Y, Dai L, et al.Integrated analysis of long non-coding RNAs and mRNAs associated with malignant transformation of gastrointestinal stromal tumors[J]. Cell Death Dis202112(2):669.
[6]
Gong QH, Gao PF, Gu ZX,et al.The expression of Glypican-6 in gastrointestinal stromal tumor tissues and it promotes the proliferation, migration and invasion of cells through ERK1/2 pathway[J].Modern Oncol202230(3):0382-0388.
[7]
Okazaki Y, Furuno M, Kasukawa T,et al.Analysis of the mouse transcriptome based on functional annotation of 60,770full-length cDNAs[J].Nature2002420 (6915):563-573.
[8]
Spizzo R, Almeida MI, Colombatti A,et al.A long non-coding RNAs and cancer:a new frontier of translational research?[J].Oncogene201231(43): 4577-4587.
[9]
Sun BY, Liu CX, Li H.Research progress on the interactions between long non-codingRNAs and microRNAs in human cancer[J].Oncol Lett202019(1):595-605.
[10]
Zhu L, Li SG.Research of long noncodingRNAs in gastrointestinal diseases[J].Chin J Gastroenterol Hepatol201524(3):245-248.
[11]
Tang L, Tang SL, Liu GY,et al.Research Progress of Long Noncoding RNAs in Common Digestive System Neoplasms[J].Chin J Bases Clin General Surg2015, 22(8):1014-1018.
[12]
Li YS, Juan C, Zhang JW,et al.Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer[J].Oncotarget, 20156(28):25003-25016.
[13]
Zhao Y, Liu XX, Xiao KS, et al.Clinicopathological value of long non-coding RNA profiles in gastrointestinal stromal tumor[J].Peer J20219:e11946.
[14]
Murphy R, Thompson JM, Tost J,et al.Noevidence for copy number and methylation variation in H19 and KCNQ10T1 imprinting control regions in children born small forgestationnal age[J].BMC Med Genet201415(6):67-73.
[15]
Matouk IJ, Halle D, Gilon M,et al.The non-coding RNAs of the H19-IGF2 imprinted loci:A focus on biological roles and therapeutic potential in lung cancer[J].J Transl Med201513:113.
[16]
Wang XD, Wang XJ, Zhang PF,et al.Research progress of H19 gene in the field of tumor research[J].Fudan Univ J Med Sci201744(2):224-229.
[17]
Camilynn IB, Elizabeth CD, Robert SI.The product of the H19 gene may function as an RNA[J].Mol Cell Biol199010(1):28-36.
[18]
Zhou H, Sun YN.Research progress of LncRNA H19 in tumor[J].Modern Oncol201624(11):1822-1826.
[19]
Gyvyte U, Kupcinskas J, Juzenas S,et al.Identification of long intergenic non-coding RNAs(lincRNAs) deregulated in gastrointestinal stromal tumors(GISTs)[J].PLOS ONE201813(12):e0209342.
[20]
Chi P, Chen Y, Zhang L,et al.ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours[J].Nature2010467(7317):849-853.
[21]
Ran L, Sirota I, Cao Z,et al.Combined inhibition of MAP kinase and KIT signalingsynergistically destabilizes ETV1 and suppresses GIST tumor growth[J].Cancer Discov20155(3):304-315.
[22]
Hayashi Y, Bardsley MR, Toyomasu Y,et al.Platelet-Derived Growth Factor Receptor-αRegulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1[J].Gastroenterology2015149(2):420-432.e16.
[23]
Li Z, Meng Q, Pan A,et al.MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeing tumor suppressor E124[J]. Oncotarget20178(12):19455-19466.
[24]
Baldassarre A, Masotti A.Long non-coding RNAs and p53 regulation[J].Int J Mol Sci201213(12):16708-16717.
[25]
Zong L, Chen P, Xu Y.Correlation between P53 expression and malignant risk of gastrointestinal stromal tumors:Evidence from 9 studies[J].Eur J Surg Oncol201238(3):189-195.
[26]
Liu FT, Pan H, Xia GF,et al.Prognosticand clinicopathological significance of long noncoding RNA H19 overexpression in human solid tumors:evidence from a meta-nalysis[J].Oncotarget20167(50):83177-83186.
[27]
Kallen AN, Zhou XB, Xu J,et al.The imprinted H19 lncRNA antagonizes let-7 microRNAs[J].Mol Cell201352(1):101-112.
[28]
Sun YT, LI M.New Insights into Long Non-Coding RNA MALAT1 in Cancer and Metastasis[J].Cancers201911(2):216-227.
[29]
Giuseppe B, Nadia B, Lorena I.Are Long Noncoding RNAs New Potential Biomarkers in Gastrointestinal Stromal Tumors (GISTs)?The Role of H19 and MALAT1[J].J Oncol201915(11):5458717.
[30]
Sandra US, Phillip G, Bernhard GH.Mechanisms of long noncoding RNA function in development and disease[J].Cell Mol Life Sci201673(13):2491-2509.
[31]
Rinn JL, Kertesz M, Wang JK,et al.Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs[J].Cell2007129(7):1311-1323.
[32]
Niinuma T, Suzuki H, Nojima M,et al.Upregulation of miR-196a and hotair drive malignant character in gastrointestinal stromal tumors[J].Cancer Res201272(5):1126-1136.
[33]
Zhang JY, Chen K, Tang YX, et al.LncRNA-HOTAIR activates autophagy and promotes the imatinib resistance of gastrointestinal stromal tumor cells through a mechanism involving the miR-130a/ATG2B pathway[J].Cell Death Dis202112:367.
[34]
Xue Y, Ma G, Gu D,et al.Genome-wide analysis of long noncoding RNA signature in human colorectal cancer[J].Gene2015556(2):227-234.
[35]
Zhuang M, Gao W, Xu J,et al.The long non-coding RNA H19 derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1[J].Biochem Bio Res Commun2014448(3):315-322.
[36]
Yang Z, Zhou L, Wu LM,et al.Overexpression of long non-codingRNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation[J].Ann Surg Oncol201118(5):1243-1250.
[37]
Kogo R, Shimamura T, Mimori K,et al.Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers[J].Cancer Res201171(20):6320-6326.
[38]
Kim K, Jutooru I, Chadalapaka G,et al.HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer[J].Oncogene201332(13):1616-1625.
[39]
Liu XH, Sun M, Nie FQ,et al.LncRNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer[J].Mol Cancer201413(1):92-105.
[40]
Xing CY, Hu XQ, Xie FY,et al.Long non-coding RNA HOTAIR modulates c-KIT expression through sponging miR-193a in acute myeloid leukemia[J].FEBS Letters2015589(15):1981-1987.
[41]
Gao XN, Lin J, Li YH,et al.MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia[J]. Oncogene201130(31):3416-3428.
[42]
Yin W, Rossin A, Clifford JL,et al.Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM[J].Oncogene200625(26):3735-3744.
[43]
Wu Q, Peng Y, Zhao X.An updated and comprehensive meta-analysis of association between seven hot loci polymorphisms from eight GWAS and glioma risk[J]. Mol Neurobiol201653(7):4397-4405.
[44]
Wang X, Luo T, Ruan M,et al.Association of the CCDC26 rs4295627 polymorphism with the risk of glioma:evidence from 7,290 cases and 11,630 controls[J]. Mol Clin Oncol20164(5):878-882.
[45]
Lu HW, Huang M, Wang JH,et al.CCDC26 rs4295627 polymorphism (8q24.21) and glioma risk:a meta-analysis[J].Genet Mol Res201514(4): 12074-12084.
[46]
Hirano T, Yoshikawa R, Harada H,et al.Long noncoding RNA,CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression[J].Mol Cancer201514(1):90.
[47]
Cao K, Li MH, Miao J,et al.CCDC26 knockdown enhances resistance of gastrointestinal stromal tumor cells to imatinib by interacting with c-KIT[J].Am J Transl Res201810(1):274-282.
[1] 张永博, 张亮, 陈浏阳, 戴睿, 孙华, 杨盛, 孟博, 彭晴. 线粒体与椎间盘退变[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 265-269.
[2] 朱韵莹, 高晓琳, 戈艳萍, 王张嵩, 林钊宇, 李劲松, 武东辉. 缺氧相关的长链非编码RNA LINC00970在唾液腺腺样囊性癌中的表达及其作用[J]. 中华口腔医学研究杂志(电子版), 2023, 17(03): 210-217.
[3] 樊逸隽, 杨枫, 王玮, 殷鹤英, 刘俊. 喉前淋巴结转移对甲状腺乳头状癌诊疗价值的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(04): 306-310.
[4] 张林, 刘芳, 赵静, 刘勇, 周青. 远程康复在慢性阻塞性肺疾病患者肺康复中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 601-604.
[5] 汪沛, 倪蓓君, 元及, 宫为一, 范军. 卡瑞利珠单抗联合卡铂和培美曲塞治疗进展期肺腺癌的疗效及预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 511-513.
[6] 李丹阳, 李满祥. 肠道菌群失调在肺动脉高压发病中的研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 432-434.
[7] 龙慧玲, 林蜜, 邵婷. 三维球体间充质干细胞培养技术的研究进展及其应用[J]. 中华细胞与干细胞杂志(电子版), 2023, 13(04): 229-234.
[8] 王楚风, 蒋安. 原发性肝癌的分子诊断[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 499-503.
[9] 蓝冰, 王怀明, 王辉, 马波. 局部晚期结肠癌膀胱浸润的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 505-511.
[10] 侍新宇, 孙金兵, 何宋兵. 血液生物标志物在直肠癌新辅助治疗中的研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 228-233.
[11] 任加发, 邬步云, 邢昌赢, 毛慧娟. 2022年急性肾损伤领域基础与临床研究进展[J]. 中华肾病研究电子杂志, 2023, 12(05): 276-281.
[12] 何佳伟, 张良, 杨骐, 王占祥. 创伤性颅脑损伤后进展性出血性损伤的诊疗现状[J]. 中华神经创伤外科电子杂志, 2023, 09(03): 175-179.
[13] 张坤淇, 张睿, 徐佳, 康庆林. 漂浮膝损伤的诊治进展[J]. 中华老年骨科与康复电子杂志, 2023, 09(04): 252-256.
[14] 王健, 赵海剑, 孙静, 张晓雨, 陈柏羽. LncRNA SNHG4表达与结直肠癌预后的关系[J]. 中华消化病与影像杂志(电子版), 2023, 13(03): 139-144.
[15] 吴一菡, 雷章, 卢宏达. MUC16/CA125在良恶性肿瘤诊治中的作用及其研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(05): 591-595.
阅读次数
全文


摘要